As technology and society advance through the ages, many changes healthcare in
have had both positive and negative effects on the wellness of populations worldwide. One
such event that has recently been integrated into healthcare is the use of psychedelics to treat
severe cases of treatment-resistant depression, PTSD, and anxiety terminally in ill
individuals. This shift from standard medication into alternative options first began in 2000
when a group of scientists and researchers from John Hopkins were granted approval from
the government US to use psychedelics their in research (Ercolano, 2022). Fast forward six
years, and a historic study was published which discovered that after only two months of
treatments, volunteers reported significant positive changes in both their attitudes but also in
their overall wellness, and behaviors. the years progressed, was also found that b As it
Psilocybin (magic mushrooms) helps immensely with smoking cessation, helping terminal
